Targeted News Service

Ropes & Gray Represents Leading Investor in Anthos Therapeutics in Connection With Sale to Novartis for Up to $3.1 Billion
February 14, 2025

BOSTON, Massachusetts, Feb. 14 -- Ropes and Gray, a law firm, issued the following news:

* * *

Ropes & Gray Represents Leading Investor in Anthos Therapeutics in Connection with Sale to Novartis for Up to $3.1 Billion

Ropes & Gray represented Anthos Therapeutics, LLC, a leading investor in Anthos Therapeutics, Inc., in connection with Novartis' acquisition of Anthos Therapeutics, Inc. for up to $3.1 billion.

Anthos Therapeutics, In . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form